<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Miami</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Miami, Florida, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Private research university</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1925</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.miami.edu/" target="_blank">University of Miami official site</a></td>
</tr>
<tr>
<td class="label">Neurodegeneration Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease, Tauopathies, Neurodegeneration</td>
</tr>
<tr>
<td class="label">Major Units</td>
<td>University of Miami Miller School of Medicine, Department of Neurology, Center for Cognitive Neuroscience and Aging</td>
</tr>
</table>
University of Miami
Overview
Mermaid diagram (expand to render)
University Of Miami plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
The University of Miami is a major private research university in South Florida, founded in 1925. The Miller School of Medicine houses comprehensive research and clinical programs in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The university is a leading institution in the southeastern United States for neuroscience research and clinical care [1].
Academic Medical Center
Miller School of Medicine
The Miller School of Medicine is the largest medical school in the southeastern United States, with over $400 million in annual research funding. The school's Department of Neurology is a major center for neurodegenerative disease research and patient care [2].
Leonard M. Miller School of Medicine Rankings
- Top 50 medical schools for research (U.S. News & World Report)
- Leading institution for Alzheimer's disease clinical trials
- Comprehensive movement disorders program
Research Programs
Center for Cognitive Neuroscience and Aging (CCNA)
The CCNA is a major research hub focusing on:
- Alzheimer's Disease: Early detection, biomarker development, and clinical trials for disease-modifying therapies
- Parkinson's Disease: Motor and non-motor symptom research, including cognitive impairment and depression
- Vascular Dementia: Cerebrovascular contributions to cognitive decline, small vessel disease
- Mild Cognitive Impairment: Early intervention strategies and progression prediction
- Lewy Body Dementia: [Alpha-synuclein](/proteins/alpha-synuclein) pathology and clinical correlations
Department of Neurology
The Department of Neurology provides comprehensive clinical care and conducts research in:
- Alzheimer's Disease: Amyloid and [tau](/proteins/tau) pathology mechanisms, clinical manifestations, therapeutic interventions targeting [amyloid-beta](/proteins/amyloid-beta) and tau
- Parkinson's Disease: Alpha-synuclein biology, Lewy body disease, deep brain stimulation outcomes
- ALS: Genetic and molecular mechanisms of motor neuron disease, including [C9orf72](/entities/c9orf72) and SOD1 mutations
- Frontotemporal Dementia: [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology and clinical variants, behavioral and language presentations
Institute for Brain Health
The Institute for Brain Health at the University of Miami focuses on:
- Preventing cognitive decline
- Optimizing brain health across the lifespan
- Developing novel therapeutic approaches
Key Research Areas
Alzheimer's Disease Research
University of Miami researchers investigate:
- Amyloid-beta immunotherapy clinical trials
- Tau PET imaging biomarkers
- Genetic risk factors in diverse populations
- Neuroinflammation mechanisms
- Early detection and prevention strategies
Parkinson's Disease Research
Research programs focus on:
- Alpha-synuclein aggregation and spread
- GBA gene mutations in PD risk
- Deep brain stimulation programming
- Non-motor symptoms (cognitive decline, depression)
- Levodopa-induced dyskinesias
Neurodegeneration Mechanisms
The university studies fundamental mechanisms:
- Mitochondrial dysfunction in neurodegeneration
- Oxidative stress responses
- Protein quality control ([autophagy](/entities/autophagy), ubiquitin-proteasome)
- Neuroinflammation and glial biology
- Synaptic dysfunction
Clinical Programs
Memory Disorders Clinic
The Memory Disorders Clinic provides:
- Comprehensive cognitive evaluation
- State-of-the-art diagnostic testing
- Clinical trials for new treatments
- Patient and family support services
Movement Disorders Center
The Movement Disorders Center offers:
- Deep brain stimulation programming
- Botulinum toxin injections
- Physical and occupational therapy
- Clinical trials for Parkinson's disease
Notable Researchers
Dr. R. Scott Turner
Dr. Turner directs the Memory Disorders Program and leads clinical trials for Alzheimer's disease therapeutics. His research focuses on amyloid-targeting immunotherapies [3].
Dr. Alexander H. G. Martel
Dr. Martel's research focuses on Parkinson's disease and movement disorders, including deep brain stimulation outcomes and novel therapeutic approaches.
Dr. Tatjana Rundek
Dr. Rundek studies vascular contributions to cognitive impairment and Alzheimer's disease, with a focus on stroke prevention and brain health.
Training Programs
The University of Miami offers:
- Neurology residency program
- Movement Disorders fellowship
- Cognitive Neurology fellowship
- PhD programs in Neuroscience
- Postdoctoral research positions
The university's neuroscience research has significant impact:
- Serving diverse patient populations in South Florida
- Clinical trials access for underserved communities
- Community education programs on brain health
- Caregiver support and resources
See Also
- [Institutions](/institutions) - All institution pages
- [Alzheimer's Disease](/diseases/alzheimers-disease) - Alzheimer's disease mechanisms
- [Parkinson's Disease](/diseases/parkinsons-disease) - Parkinson's disease mechanisms
External Links
- [University of Miami](https://www.miami.edu/)
- [Miller School of Medicine](https://med.miami.edu/)
- [Department of Neurology](https://neurology.med.miami.edu/)
- [Center for Cognitive Neuroscience and Aging](https://ccna.med.miami.edu/)
Overview
University Of Miami plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of University Of Miami has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Unknown, University of Miami Official Site (n.d.)
Unknown, Miller School of Medicine (n.d.)
Unknown, Department of Neurology (n.d.)